Skip to main content
OpenTrials

Clinical trial condition

PD-L1-selected Solid Tumors

Explore clinical trials studying PD-L1-selected Solid Tumors. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

PD-L1-selected Solid Tumors trial results

Completed

A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors

NCT05661578

Conditions
PD-L1-selected Solid Tumors
Locations
  • Medical Oncology Associates Spokane, Washington, United States
  • Chongqing Sanxia Central Hospital Chongqing, China
  • General Hospital Pula Pula, Croatia
  • Klinicki bolnicki centar Zagreb Zagreb, Croatia
View all 32 locations
View Trial Details